Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Its that time of year again....

<< Previous

Bullboard Posts

Next >>

Comment by Hcallahan44on Oct 31, 2022 11:35am

130 Views

Post# 35060180

RE:RE:Its that time of year again....

I am not Matt but he sure has some interesting points. What is your opportunity cost noteable. you have been pumping this for years with zero appreciation. Never mind the amount of time you have spend on DD. If you had spent that time working at McDonalds you would be retired....

<< Previous

Bullboard Posts

Next >>

Changing Europe’s dependency on HREE from China